Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

A new drug for treating a type of inflammatory bowel disease (IBD) has been given the go-ahead by the Food and Drug Administration. On Friday, the FDA approved Pfizer’s etrasimod, branded as Velsipity ...

A drug that Bristol Myers Squibb is developing for use across a wide range of autoimmune diseases has failed a mid-stage clinical trial in ulcerative colitis, dimming its prospects in that indication.

French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

You’ve followed your ulcerative colitis (UC) treatment plan to a T, and yet you’re still experiencing symptoms that won’t let up — or even seem to be taking a turn for the worse. There’s an ...

A medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis in the findings of a global study led by University of Chicago ...

The goal of any ulcerative colitis treatment is to help you reach both clinical remission (an absence of symptoms) and endoscopic remission (a healing of the bowel’s mucosal lining). “People with ...

Lymphocytic colitis is a type of microscopic colitis that causes persistent, watery diarrhea. Experts still do not know the exact underlying cause. Microscopic colitis involves inflammation of the ...